… ) pathway, we decided to review the previous data regarding the therapeutic effect of mTOR
inhibitor drugs in COVID-19 … The findings of the current study confirmed that mTOR inhibitor …

… inhibition in the treatment of COVID-19. Despite these similarities, COVID-19 and other zoonotic
coronavirus-… COVID-19 pandemic on the treatment of patients with rheumatic diseases. …

… Effective treatment strategies for severe coronavirus disease (COVID-19) remain scarce. …
-ceramide pathway in 23 intensive care patients with severe COVID-19. We observed an …

… directed therapies (HDTs) effective against viral infections with a special focus on COVID-19…
-2 replication, which was confirmed with low viral load in the presence of pathway inhibitors. …

… By inhibiting the Janus kinase (JAK)-signal transducer and activator of transcription (JAK-STAT)
pathway, JAK inhibitors are hypothesized to play a role in the management of CRS in …

… and mTOR signaling pathways might provide therapeutic relief against COVID-19. Here, we
… inhibit SARS-CoV-2 infectivity and thereby might be repurposed for use against COVID-19. …

… of action of SFJDC as a potential drug for the treatment of COVID-19. Furthermore, the
study should determine the clinical effectiveness of SFJDC for the treatment of COVID-19. …

… with fatal prognosis in COVID-19 infection, and growing … 183 patients with confirmed
COVID-19 pneumonia in Wuhan… reduced thrombus plasminogen activator inhibitor-1 (PAI-1), …

… -CoV-2 entry into cells and its inhibition by antibodies (4), to analyze the role of amino acid
residue 484 in host cell entry and its inhibition (see material and methods in the supplement). …

… Baricitinib, a JAK1/2 pathway inhibitor, was tested in a double-blind, randomized, … COVID-19
demonstrated that a short 3-day treatment with IV RDV significantly reduced COVID-19 …